PTC Therapeutics (BH3.XETRA) Q2 2026 Earnings

7MayConfirmed
Q2 2026
-0.4
-0.28
-0.15
-0.03

Details

Expected EPS
-0.40223513512000003
Actual EPS
-0.0255801
Surprise EPS
0.38
Surprise Percent
+93.64%

Description

PTC Therapeutics (BH3.XETRA) has reported earnings of -0.0255801 per share for Q2 2026.

0 Comments

Share your thoughts